Cargando…

The immune evasion ability of Delta variant is comparable to that of Beta variant in South Africa

BACKGROUND: The high immune evasion ability of SARS-COV-2 Omicron variant surprised the world and appears to be far stronger than any previous variant. Previous to Omicron it has been difficult to assess and compare immune evasion ability of different variants, including the Beta and Delta variants,...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Daihai, Chen, Boqiang, Zhao, Shi, Stone, Lewi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020070/
https://www.ncbi.nlm.nih.gov/pubmed/36927400
http://dx.doi.org/10.1186/s12889-023-15431-2
_version_ 1784908170566565888
author He, Daihai
Chen, Boqiang
Zhao, Shi
Stone, Lewi
author_facet He, Daihai
Chen, Boqiang
Zhao, Shi
Stone, Lewi
author_sort He, Daihai
collection PubMed
description BACKGROUND: The high immune evasion ability of SARS-COV-2 Omicron variant surprised the world and appears to be far stronger than any previous variant. Previous to Omicron it has been difficult to assess and compare immune evasion ability of different variants, including the Beta and Delta variants, because of the relatively small numbers of reinfections and because of the problems in correctly identifying reinfections in the population. This has led to different claims appearing in the literature. Thus we find claims of both high and low immune evasion for the Beta variant. Some findings have suggested that the Beta variant has a higher immune evasion ability than the Delta variant in South Africa, and others that it has a lower ability. METHOD: In this brief report, we re-analyse a unique dataset of variant-specific reinfection data and a simple model to correct for the infection attack rates of different variants. RESULT: We find that a model with the Delta variant having  an equal or higher immune evasion ability than Beta variant is compatible with the data. CONCLUSION: We conclude that the immune evasion ability of Beta variant is not stronger than Delta variant, and indeed, the immune evasion abilities of both variants are weak in South Africa. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12889-023-15431-2.
format Online
Article
Text
id pubmed-10020070
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-100200702023-03-17 The immune evasion ability of Delta variant is comparable to that of Beta variant in South Africa He, Daihai Chen, Boqiang Zhao, Shi Stone, Lewi BMC Public Health Research BACKGROUND: The high immune evasion ability of SARS-COV-2 Omicron variant surprised the world and appears to be far stronger than any previous variant. Previous to Omicron it has been difficult to assess and compare immune evasion ability of different variants, including the Beta and Delta variants, because of the relatively small numbers of reinfections and because of the problems in correctly identifying reinfections in the population. This has led to different claims appearing in the literature. Thus we find claims of both high and low immune evasion for the Beta variant. Some findings have suggested that the Beta variant has a higher immune evasion ability than the Delta variant in South Africa, and others that it has a lower ability. METHOD: In this brief report, we re-analyse a unique dataset of variant-specific reinfection data and a simple model to correct for the infection attack rates of different variants. RESULT: We find that a model with the Delta variant having  an equal or higher immune evasion ability than Beta variant is compatible with the data. CONCLUSION: We conclude that the immune evasion ability of Beta variant is not stronger than Delta variant, and indeed, the immune evasion abilities of both variants are weak in South Africa. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12889-023-15431-2. BioMed Central 2023-03-17 /pmc/articles/PMC10020070/ /pubmed/36927400 http://dx.doi.org/10.1186/s12889-023-15431-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
He, Daihai
Chen, Boqiang
Zhao, Shi
Stone, Lewi
The immune evasion ability of Delta variant is comparable to that of Beta variant in South Africa
title The immune evasion ability of Delta variant is comparable to that of Beta variant in South Africa
title_full The immune evasion ability of Delta variant is comparable to that of Beta variant in South Africa
title_fullStr The immune evasion ability of Delta variant is comparable to that of Beta variant in South Africa
title_full_unstemmed The immune evasion ability of Delta variant is comparable to that of Beta variant in South Africa
title_short The immune evasion ability of Delta variant is comparable to that of Beta variant in South Africa
title_sort immune evasion ability of delta variant is comparable to that of beta variant in south africa
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020070/
https://www.ncbi.nlm.nih.gov/pubmed/36927400
http://dx.doi.org/10.1186/s12889-023-15431-2
work_keys_str_mv AT hedaihai theimmuneevasionabilityofdeltavariantiscomparabletothatofbetavariantinsouthafrica
AT chenboqiang theimmuneevasionabilityofdeltavariantiscomparabletothatofbetavariantinsouthafrica
AT zhaoshi theimmuneevasionabilityofdeltavariantiscomparabletothatofbetavariantinsouthafrica
AT stonelewi theimmuneevasionabilityofdeltavariantiscomparabletothatofbetavariantinsouthafrica
AT hedaihai immuneevasionabilityofdeltavariantiscomparabletothatofbetavariantinsouthafrica
AT chenboqiang immuneevasionabilityofdeltavariantiscomparabletothatofbetavariantinsouthafrica
AT zhaoshi immuneevasionabilityofdeltavariantiscomparabletothatofbetavariantinsouthafrica
AT stonelewi immuneevasionabilityofdeltavariantiscomparabletothatofbetavariantinsouthafrica